Buy NeuBase Therapeutics Inc Stock | NBSE Stock Price & Latest News | Public
NBSE

NeuBase Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap

    About NBSE

    NeuBase Therapeutics, Inc. engages in the development of drugs for patients with genetic neurological disorder. Its pipelines include Huntington’s Disease, NT0100 Program - PATrOL Enabled gamma-PNA for Huntington's Disease, and NT0200 Program- PATrOL Enabled gamma-PNA f...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.09
    -0.17
    -0.26
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.21

    Actual EPS
    Q3 2020

    Stats

    Market Cap$187,06M
    Volume2,19k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$11.78
    1 Year Low$4.52
    Open$8.02
    High$8.21
    Low$7.90

    Buy any stock with any amount of money.

    Download the App
    Download the app